An innovation by Bangalore based scientists is saving the lives of new born babies. Their diagnostic technology is able to detect neonatal sepsis faster, with greater accuracy. In an experiment conducted at JIPMER, Puduchery, they proved their effectiveness by achieving 82% drop in neonatal deaths.
This breakthrough innovation comes from a team of scientists from a diagnosis start-up called XCyton, based in Bangalore. XCyton is among the few companies in India that has been able to make an impactful medical innovation like this.
The principal scientist and founder of Xcyton, Dr. Ravi Kumar Banda, along with his team, successfully discovered this methodology of detecting the pathogens causing sepsis, known as Syndrome Evaluation System (SES).
Apart from being a lifesaving technology, it reduced ICU stays, duration of ventilation, number of drugs given to maintain blood pressure, and the number of antibiotics used per baby. This study was published in the prestigious Indian Journal of Paediatrics.